Background: Human papillomavirus (HPV) vaccination targeting females 12-13 years commenced in Australia in 2007, with catch-up of females 13-26 years until the end of 2009. No analyses of HPV vaccination program impact by either socioeconomic or geographic factors have been reported for Australia. Methods: Hospital admissions between July 2004-June 2011 involving a diagnosis of genital warts were obtained from a comprehensive national database. We compared sex- and age-specific admission rates in July 2006-June 2007 (pre-vaccination period) and July 2010-June 2011 (post-vaccination period) according to Index of Relative Socio-economic Disadvantage, nationally and stratified by remoteness area relating to the individual's area of residence, ...
Objective: To determine whether HPV vaccine coverage in 12–13-year-olds varies by geographical area,...
BACKGROUND: For several decades, diagnoses of genital warts at genitourinary medicine (GUM) clinics ...
Abstract Objective: To determine whether HPV vaccine coverage in 12–13‐year‐olds varies by geographi...
Background. Human papillomavirus (HPV) vaccination targeting females aged 12–13 years commenced in A...
Background. Human papillomavirus (HPV) vaccination targeting females aged 12–13 years commenced in A...
BACKGROUND: There has been a rapid decline in the number of young heterosexuals diagnosed with genit...
ABSTRACT: Background: Substantial declines in genital warts have been observed in countries with qua...
OBJECTIVES: Since the introduction of Australia's human papillomavirus vaccination program, the mana...
OBJECTIVES: Since the introduction of Australia's human papillomavirus vaccination program, the mana...
Background Australia has provided free quadrivalent human papillomavirus (HPV) vaccines to school gi...
Since the introduction of Australia's human papillomavirus vaccination program, the management rate ...
Since the introduction of Australia's human papillomavirus vaccination program, the management rate ...
Background: Australia provided free quadrivalent human papillomavirus vaccines to 12-18-year-old gir...
Objectives: Australia introduced a nationwide human papillomavirus (HPV) vaccination programme for w...
OBJECTIVES To examine the impact of the national human papillomavirus (HPV) vaccination program (...
Objective: To determine whether HPV vaccine coverage in 12–13-year-olds varies by geographical area,...
BACKGROUND: For several decades, diagnoses of genital warts at genitourinary medicine (GUM) clinics ...
Abstract Objective: To determine whether HPV vaccine coverage in 12–13‐year‐olds varies by geographi...
Background. Human papillomavirus (HPV) vaccination targeting females aged 12–13 years commenced in A...
Background. Human papillomavirus (HPV) vaccination targeting females aged 12–13 years commenced in A...
BACKGROUND: There has been a rapid decline in the number of young heterosexuals diagnosed with genit...
ABSTRACT: Background: Substantial declines in genital warts have been observed in countries with qua...
OBJECTIVES: Since the introduction of Australia's human papillomavirus vaccination program, the mana...
OBJECTIVES: Since the introduction of Australia's human papillomavirus vaccination program, the mana...
Background Australia has provided free quadrivalent human papillomavirus (HPV) vaccines to school gi...
Since the introduction of Australia's human papillomavirus vaccination program, the management rate ...
Since the introduction of Australia's human papillomavirus vaccination program, the management rate ...
Background: Australia provided free quadrivalent human papillomavirus vaccines to 12-18-year-old gir...
Objectives: Australia introduced a nationwide human papillomavirus (HPV) vaccination programme for w...
OBJECTIVES To examine the impact of the national human papillomavirus (HPV) vaccination program (...
Objective: To determine whether HPV vaccine coverage in 12–13-year-olds varies by geographical area,...
BACKGROUND: For several decades, diagnoses of genital warts at genitourinary medicine (GUM) clinics ...
Abstract Objective: To determine whether HPV vaccine coverage in 12–13‐year‐olds varies by geographi...